Spots Global Cancer Trial Database for chemotherapy, adjuvant
Every month we try and update this database with for chemotherapy, adjuvant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients | NCT00470340 | Liver Neoplasms Liver Cirrhosis Carcinoma, Hepa... Recurrence Neoplasm Recurr... | Oxaliplatin, ge... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
TAilored Post-Surgical Therapy in Early Stage NSCLC | NCT00775385 | Carcinoma, Non-... | Standard Chemot... Customized Trea... | 18 Years - 70 Years | Intergroupe Francophone de Cancerologie Thoracique | |
Adjuvant FEC Versus EP in Breast Cancer (MIG5) | NCT02450058 | Breast Cancer Chemotherapy, A... | 5-fluorouracil epirubicin cyclophosphamid... epirubicin paclitaxel | 18 Years - 70 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC | NCT05167604 | Carcinoma, Non-... Next-Generation... Chemotherapy, A... Neoplasm, Resid... Circulating Tum... | Adjuvants, Phar... | 18 Years - 70 Years | Tang-Du Hospital | |
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | NCT00246597 | Anemia Breast Neoplasm... Hemoglobins Quality of Life Chemotherapy, A... | epoetin alfa | 18 Years - | Ortho Biotech Products, L.P. | |
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. | NCT06295094 | Gastric Cancer Chemotherapy, A... Peritoneal Meta... Minimally Invas... | Cisplatin Doxorubicin | 18 Years - 80 Years | Odense University Hospital | |
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome | NCT03761420 | Breast Neoplasm | 20 Years - 100 Years | St. Olavs Hospital | ||
Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC | NCT03712969 | Carcinoma, Non-... Chemotherapy, A... | Shenlingcao Ora... | 18 Years - | West China Hospital | |
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC | NCT05167604 | Carcinoma, Non-... Next-Generation... Chemotherapy, A... Neoplasm, Resid... Circulating Tum... | Adjuvants, Phar... | 18 Years - 70 Years | Tang-Du Hospital | |
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer | NCT03011060 | Breast Neoplasm... | Neo-adjuvant Ch... Capecitabine | 18 Years - 70 Years | The First Hospital of Jilin University | |
The Stoma Closure Before or After Adjuvant Therapy Trial | NCT04372992 | Ileostomy Rectal Cancer | Timing of stoma... | 18 Years - | Ospedale Umberto I di Torino | |
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients | NCT00470340 | Liver Neoplasms Liver Cirrhosis Carcinoma, Hepa... Recurrence Neoplasm Recurr... | Oxaliplatin, ge... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection | NCT03479294 | Carcinoma, Non-... Chemotherapy, A... | Shenlingcao Ora... | 18 Years - | West China Hospital | |
Acute Exercise Cardioprotection From Doxorubicin | NCT02006979 | Breast Cancer | exercise | 18 Years - | University of British Columbia | |
Adjuvant FEC Versus EP in Breast Cancer (MIG5) | NCT02450058 | Breast Cancer Chemotherapy, A... | 5-fluorouracil epirubicin cyclophosphamid... epirubicin paclitaxel | 18 Years - 70 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
TAilored Post-Surgical Therapy in Early Stage NSCLC | NCT00775385 | Carcinoma, Non-... | Standard Chemot... Customized Trea... | 18 Years - 70 Years | Intergroupe Francophone de Cancerologie Thoracique | |
Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer | NCT03277898 | Breast Neoplasm... | Aerobic Exercis... Usual Care (Wai... | 19 Years - 70 Years | University of British Columbia | |
Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress | NCT01264562 | Breast Cancer | 18 Years - 65 Years | Ludwig-Maximilians - University of Munich | ||
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. | NCT06295094 | Gastric Cancer Chemotherapy, A... Peritoneal Meta... Minimally Invas... | Cisplatin Doxorubicin | 18 Years - 80 Years | Odense University Hospital | |
Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome | NCT03761420 | Breast Neoplasm | 20 Years - 100 Years | St. Olavs Hospital | ||
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients | NCT00470340 | Liver Neoplasms Liver Cirrhosis Carcinoma, Hepa... Recurrence Neoplasm Recurr... | Oxaliplatin, ge... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection | NCT03479294 | Carcinoma, Non-... Chemotherapy, A... | Shenlingcao Ora... | 18 Years - | West China Hospital |